Who we are
AusCann is an Australian-based company focused on the development and commercialisation of cannabinoid-derived therapeutic products to address unmet needs for humans within Australia and internationally.
Our key difference is the commitment to rigorous product development, focused on providing reliable, stable and standardised cannabinoid-derived therapeutics products, whilst generating robust safety, quality assurance and efficacy data to support market access in various regulatory environments around the world.
What we do
Improve health outcomes and quality of life for patients around the world.
We have built a strong team of experts and partners in human health, with the right expertise across all aspects of the pharmaceutical value chains.
Our immediate focus is on providing both healthcare professionals with solutions to optimise treatment outcomes for patients. To do that, we have developed innovative technologies to enhance the delivery of our novel formulations and aim to commercialise our products through various regulatory frameworks around the world.
How we improve human health
Driven by unmet medical needs and backed by pharmaceutical and nutraceutical science, AusCann aims to transform the way cannabinoid and hemp-derived products are used today by developing and making available a range of standardised, innovative and reliable products with a focus on safety and quality assurance.
The Company has launched novel tetrahydrocannabinol and cannabidiol (THC/CBD) powder-based hard-shell capsules, based on AusCann’s proprietary Neuvis® platform, for the treatment of pain and related indications. The capsules address key concerns raised by healthcare professionals for alternative cannabinoid dose forms, which offer enhanced patient compliance, ease-of-use for patients with dexterity issues, dose uniformity and eliminate potential in-use contamination.
Further Information for healthcare professionals regarding our standardised THC/CBD powder-based capsules using the Neuvis® drug delivery system is available at neuvis.com